These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 2905335)
1. [Pharmacologic portrait of enalapril]. Rahn KH Fortschr Med Suppl; 1988; 52():4-5. PubMed ID: 2905335 [No Abstract] [Full Text] [Related]
2. Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure. Cody RJ; Laragh JH; Atlas SA; Case DB J Hypertens Suppl; 1983 Oct; 1(1):77-84. PubMed ID: 6085835 [TBL] [Abstract][Full Text] [Related]
3. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension. Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326 [TBL] [Abstract][Full Text] [Related]
4. [Ednit effects on activity of renin-angiotensin-aldosterone system and renal function in hypertensive subjects with diabetes mellitus]. Zonis BIa; Volkova NI; Sokolov OIu Ter Arkh; 2000; 72(2):53-5. PubMed ID: 10717928 [TBL] [Abstract][Full Text] [Related]
5. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure. Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004 [TBL] [Abstract][Full Text] [Related]
6. Enalapril in hypertension with renal artery stenosis: long-term follow-up and effects on renal function. Tillman DM; Malatino LS; Cumming AM; Hodsman GP; Leckie BJ; Lever AF; Morton JJ; Webb DJ; Robertson JI J Hypertens Suppl; 1984 Dec; 2(2):S93-100. PubMed ID: 6100883 [TBL] [Abstract][Full Text] [Related]
7. Regression of vascular structural changes and calcium metabolism in patients with essential hypertension after long-term monotherapy with enalapril. Ueno H; Takata M; Oh-hashi S; Tomoda F; Yasumoto K; Iida H; Sasayama S J Hum Hypertens; 1993 Apr; 7(2):125-30. PubMed ID: 8510084 [TBL] [Abstract][Full Text] [Related]
8. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension. O'Connor DT; Mosley CA; Cervenka J; Bernstein KN J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882 [TBL] [Abstract][Full Text] [Related]
9. Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan. Avanza AC; El Aouar LM; Mill JG Arq Bras Cardiol; 2000 Feb; 74(2):103-17. PubMed ID: 10904284 [TBL] [Abstract][Full Text] [Related]
10. [Vasodilators in the treatment of arterial hypertension]. Gherasim L; Dorobanţu M Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(4):289-302. PubMed ID: 6150533 [No Abstract] [Full Text] [Related]
11. Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease. Miller RH; Lehmkuhl LB; Smeak DD; DiBartola SP; Radin J Am J Vet Res; 1999 Dec; 60(12):1516-25. PubMed ID: 10622161 [TBL] [Abstract][Full Text] [Related]
12. Enalapril (MK421) in the treatment of hypertension with renal artery stenosis. Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI J Hypertens Suppl; 1983 Oct; 1(1):109-17. PubMed ID: 6100599 [TBL] [Abstract][Full Text] [Related]
13. [The importance of studying the renin-angiotensin-aldosterone system in essential arterial hypertension in clinical practice. Activity of the renin-angiotensin-aldosterone system during treatment of hypertension with ACE-inhibitors and beta blockers]. Hrnciar J; Hrnciarová M; Lepej J; Okálová D; Kreze A; Chamulová M Vnitr Lek; 1994 Sep; 40(9):557-62. PubMed ID: 7975357 [TBL] [Abstract][Full Text] [Related]
14. Systemic and renal effects of enalapril and its effects on cardiac mass. Dunn FG; Oigman W; Ventura HO; Messerli FH; Kobrin I; Frohlich ED J Hypertens Suppl; 1984 Dec; 2(2):S57-61. PubMed ID: 6100878 [TBL] [Abstract][Full Text] [Related]
15. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation. Häggström J; Hansson K; Karlberg BE; Kvart C; Madej A; Olsson K Am J Vet Res; 1996 Nov; 57(11):1645-52. PubMed ID: 8915446 [TBL] [Abstract][Full Text] [Related]
16. Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan. Demeilliers B; Jover B; Mimran A J Hypertens; 1995 Dec; 13(12 Pt 2):1764-6. PubMed ID: 8903648 [TBL] [Abstract][Full Text] [Related]
17. Clinical experience with converting-enzyme inhibitors in hypertension. Weber MA Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889 [TBL] [Abstract][Full Text] [Related]
18. Long-term effects of enalapril monotherapy and enalapril/hydrochlorothiazide combination therapy on blood pressure, renal function, and body fluid composition. Reams GP; Bauer JH J Clin Hypertens; 1986 Mar; 2(1):55-63. PubMed ID: 3014081 [TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid antagonists as probes to study the vascular effects of glucocorticoids. Grünfeld JP; Eloy L Kidney Int Suppl; 1988 Oct; 26():S24-6. PubMed ID: 3155426 [No Abstract] [Full Text] [Related]
20. Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification. Tokumoto M; Mizobuchi M; Finch JL; Nakamura H; Martin DR; Slatopolsky E Am J Nephrol; 2009; 29(6):582-91. PubMed ID: 19145073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]